Correlation Between Carmat SA and Astellas Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Carmat SA and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Carmat SA and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Carmat SA and Astellas Pharma, you can compare the effects of market volatilities on Carmat SA and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Carmat SA with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Carmat SA and Astellas Pharma.

Diversification Opportunities for Carmat SA and Astellas Pharma

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Carmat and Astellas is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Carmat SA and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and Carmat SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Carmat SA are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of Carmat SA i.e., Carmat SA and Astellas Pharma go up and down completely randomly.

Pair Corralation between Carmat SA and Astellas Pharma

Assuming the 90 days horizon Carmat SA is expected to under-perform the Astellas Pharma. In addition to that, Carmat SA is 3.85 times more volatile than Astellas Pharma. It trades about -0.05 of its total potential returns per unit of risk. Astellas Pharma is currently generating about -0.04 per unit of volatility. If you would invest  1,434  in Astellas Pharma on August 27, 2024 and sell it today you would lose (476.00) from holding Astellas Pharma or give up 33.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Carmat SA  vs.  Astellas Pharma

 Performance 
       Timeline  
Carmat SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Carmat SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Astellas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Carmat SA and Astellas Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Carmat SA and Astellas Pharma

The main advantage of trading using opposite Carmat SA and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Carmat SA position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.
The idea behind Carmat SA and Astellas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas